To ascertain the virulence of bovine viral diarrhea virus (BVDV) genotype II, isolate NY-93 was inoculated intranasally into 3 calves, 2 of which were treated with a synthetic glucocorticoid prior to and after virus inoculation. Anorexia, fever (up to 42 C), dyspnea, and hemorrhagic diarrhea developed 6 days after intranasal inoculation with BVDV NY-93. The condition of all calves deteriorated further until the end of the study on day 14 postinoculation. The most significant postmortem macroscopic changes in all calves were limited to the gastrointestinal tract and consisted of moderate to severe congestion of the mucosa with multifocal hemorrhages. Microscopic lesions found in the gastrointestinal tract were similar to those observed in mucosal disease, including degeneration and necrosis of crypt epithelium and necrosis of lymphoid tissue throughout the ileum, colon, and rectum. The basal stratum of the epithelium of tongue, esophagus, and rumen had scattered individual necrotic cells. Spleen and lymph nodes had lymphocytolysis and severe lymphoid depletion. Severe acute fibrinous bronchopneumonia was present in dexamethasone-treated calves. Abundant viral antigen was detected by immunohistochemistry in the squamous epithelium of tongue, esophagus, and forestomachs. BVDV antigen was prominent in cells of the media of small arteries and endothelial cells. The presence of infectious virus in tissues correlated with an absence of circulating neutralizing antibodies. These findings highlight the potential of BVDV genotype II to cause severe disease in normal and stressed cattle.
The original description of bovine viral diarrhea (BVD) in 1946 27 referred to a serious condition with high morbidity (33-88%) and significant mortality (4-8%). Years later, the causative viral agent was isolated in cell cultures, but no severe disease was observed in normal adult cattle inoculated with this or other isolates. It was concluded that prevailing strains of BVD virus (BVDV) caused only a subclinical infection or mild clinical disease. 24 BVDV virulence was considered to be limited to the developing fetus, causing abortions, developmental defects, and birth of persistently infected cattle.
BVDV is a member of the genus Pestivirus in the family Flaviviridae. 37 The majority of BVDV isolates circulating in cattle populations are noncytopathic (NCP) in cell cultures, a feature shared by many flavivirus species. Only NCP-BVDV isolates are able to cause persistent infection following fetal infection.
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Received for publication June 23, 1997. syndrome termed mucosal disease (MD). 4, 8 Animals with MD often carried not only NCP-BVDV but also a virus that induced cytopathic (CP) changes in infected cells (CP-BVDV). The antigenic similarity between both biotypes of the virus from the same animal suggested that the CP-BVDV arises from NCP-BVDV by mutation, recombination, or rearrangement. 13, 36 Genetic studies have shown that mutations and rearrangements within the nonstructural p125 (p54/p80) gene correlate with conversion of NCP-BVDV into CP-BVD. 23 Mucosal disease is thus essentially a late sequel to fetal infection with NCP-BVDV. NCP-BVDV isolates capable of causing fatal acute disease in naive immunocompetent cattle were identified in the late 1980s. 13, 32 The syndrome was characterized by widespread ecchymotic hemorrhages on mucosal surfaces and on various internal organs. 7, 29 The hallmark of these infections was a severe thrombocytopenia, which is in part responsible for the lesions observed. 12, 13, 32 At the time, these isolates were considered to be of low prevalence. Attempts to reproduce this syndrome by experimental inoculation often resulted in low morbidity and mortality rates, 5 suggesting host and environmental factor involvement. Environmental stress could lead to stimulation of the hypothalamic-adrenocortical axis with ensuing cortisol release, which is responsible for a transient and partial immunosuppression. 25 In some reported experimental infections, a course of relatively high doses of dexamethasone injected before BVDV inoculation resulted in severe infections and even the death of the animal. 10, 35 Reports from the USA, 13, 32 Canada, 9 and England 14, 15, 20 indicated a rise in the incidence of clinical BVD and an increased severity of the disease in these outbreaks, with high mortality. These outbreaks were characterized by a sudden onset of leukopenia, pyrexia, anorexia, severe diarrhea, respiratory distress, abortions, and death of young and adult cattle. These reports reinforced the emerging consensus that NCP-BVDV is capable of inducing severe disease in cattle never exposed to BVDV.
Isolates identified to date, that are capable of inducing severe or fatal acute (sometimes hemorrhagic) disease belong in a distinct lineage of BVDV, tentatively designated genotype II. 28, 34 Sequence comparison of the highly conserved 5Ј untranslated region (UTR) of these genomes revealed 75% homology with BVDV genotype I isolates. Sequence divergence in the coding region of the genome leads to important serologic differences between genotype I and genotype II BVDV isolates. 28, 34 The purpose of this study was to determine the virulence of a field isolate of BVDV genotype II in cattle treated with dexamethasone to mimic the stress normally associated with severe disease outbreaks. Under the experimental conditions described, BVDV isolate NY-93 displayed a highly virulent phenotype, causing lesions that resemble those of MD.
Materials and methods
Animals and virus inoculum. A. NCP-BVDV isolate, designated NY-93, was isolated in 1993 from an outbreak with high mortality in the state of New York. Antigenic characterization of this isolate with a panel of monoclonal antibodies (MAbs) revealed that NY-93 was similar to other genotype II isolates (E. J. Dubovi, personal communication). The virus was passed 3 times in primary bovine fetal kidney cells and 4 times in bovine testicle cells prior to generation of a stock with an infectivity of 10 7.6 TCID 50 /ml. 17 Three 6mo-old crossbred calves (A, B, and C) free of BVDV and lacking serum antibodies to BVDV were used. The calves were housed in strict isolation at an animal research facility and fed standard concentrate diet. Starting 3 days before virus inoculation, 2 calves, A and B, were treated with intravenous dexamethasone (0.1 mg/kg daily) a for a total of 5 days to induce physiologic changes analogous to those observed in stressed cattle. The remaining animal (calf C) served as an untreated control, receiving injections of saline. The virus inoculum was administered by inhalation, using a nebulizer b to administer 25 ml of tissue culture fluid containing 10 9 TCID 50 of BVDV NY-93. This time point is defined as day 0. Clinical parameters recorded included rectal temperature, alertness, appetite, respiratory rate, body condition, and presence and characteristics of diarrhea.
Pathology. A full postmortem examination was per-formed on all calves after acute death or euthanasia due to deteriorating condition, 13-14 days postinoculation (PI). Tissues obtained at necropsies were fixed by immersion in 10% neutral buffered formalin for 48 hr, followed by standard methods for preparation of histologic sections stained with hematoxylin and eosin (HE). To investigate the presence of concurrent bacterial infections, tissue and fluid samples collected aseptically during postmortem examination were submitted for aerobic and microaerophilic bacterial isolation. Viral isolation and titration. Plasma and tissue samples collected at necropsy were stored at Ϫ70 C until processed for virus isolation. At the time of virus isolation, a 10% tissue homogenate was prepared and inoculated onto cultures of bovine testicle cells. Inoculated cultures were tested for BVDV antigen by an indirect fluorescent antibody procedure with a broad-specificity MAb (20.10 and 15C15) to calculate median infective doses. 16 Virus titers were expressed as TCID 50 per gram of tissue. 33 Serum neutralization test. Sera obtained before inoculation with BVDV NY-93 and on days 0, 7, 10, and 13 PI was heat-inactivated at 56 C for 60 min and tested for neutralizing antibodies to BVDV Singer and NY-93 (heterologous and homologous strains) using standard microtitration procedures. 21 Serum samples were heat-inactivated by incubation at 56 C for 30 min to reduce levels of NCP-BVDV NY-93, which could interfere with the interpretation of results of the serum neutralization test.
Immunohistochemistry. An avidin-biotin-alkaline phosphatase complex procedure was employed to reveal the location of BVDV antigen in sections of formalin-fixed, parafin-embeded tissues. 19, 22 Tissue sections were deparaffinized and rehydrated by sequential immersion in xylene followed by graded concentrations of ethanol and 0.05 M Tris-buffered saline (TBS), pH 7.6. Sections were lightly digested by immersion of the slides in a solution of 0.5 mg of Protease XIV c in TBS for 15 min at 37 C. Following 3 washes in TBS containing 1 mM ethylenediamine tetraacetic acid (EDTA) and 0.05% Tween 20 (TBS-EDTA-Tween) for 5 min each, sections were immersed in 5% horse serum in TBS for 30 min at room temperature to saturate nonspecific protein-binding sites. Tissue sections were then flooded with BVDV-specific MAb 15C5 and incubated for 1 hr at 37 C in a humidified atmosphere. Slides were then washed 3 times in TBS-EDTA-Tween for 5 min each, and biotinylated equine anti-mouse IgG d was applied. Following incubation for 30 min at 37 C in a moist atmosphere, slides were washed 3 times in TBS-EDTA-Tween for 5 min each. Avidin-alkaline phosphatase complex e working solution was incubated on the tissue sections for 15 min at room temperature, followed by 3 rinses in TBS-EDTA-Tween for 5 min each. Sections were then exposed to the substrate f for 12 min at room temperature in the dark and then rinsed in tap water for 1 min. Gill I hematoxylin was used to counterstain all sections. The sensitivity and specificity of the staining procedures were ascertained by the introduction of controls consisting of known BVDV-negative and -positive cattle tissue samples and substitution of specific MAb 15C5 with the irrelevant MAb A15 not reactive with BVDV antigen. 
Results
Clinical response to genotype II BVDV inoculation. Anorexia, depression, and episodes of profuse watery and bloody diarrhea were the most striking clinical findings in inoculated cattle. Rectal temperatures of all calves rose to approximately 42 C on day 7 PI and remained above this value throughout the course of the experiment. After the onset of clinical signs, the animals alternated between periods of depression and anorexia and periods of brightness and apparent recovery. Calf A showed mild to moderate depression and anorexia from day 6 to day 9 PI. Respiratory distress and profuse diarrhea were noticed on day 10 PI. Symptoms ceased and calf A showed signs of recovery by days 11 and 12 PI. Profuse watery diarrhea and profound depression were observed again on day 13 PI, and the animal was euthanized on day 14 PI. Calf B had a transient episode of bloody diarrhea on day 7 PI, followed by severe respiratory distress on day 8. Signs of recovery were evident by days 9 and 10 PI. The transient recovery was followed by abrupt recrudescence of the anorexia and profuse watery diarrhea on day 12 PI. This animal died suddenly on day 13 PI. Calf C showed moderate nasal discharge of mucus on day 8 PI, which evolved into mild respiratory distress and anorexia by day 9 PI continuing until day 14 PI. A profuse watery diarrhea and worsening general condition were observed after day 12 PI. Calf C was euthanized on day 14 PI with very poor prognosis. Necropsy was conducted within approximately 3.5 hours of death on calves B and C.
Necropsy. The most relevant gross lesions found in the inoculated calves were in the digestive and respiratory system. The mucosa of the abomasum and small and large intestine of calves A and B showed severe diffuse congestion. Petechiae and ecchymosis were present throughout the intestinal mucosa of calf B. Ileocecal valve hemorrhages and severe edema in abomasum and rectum were observed in calf A. Mesenteric lymph nodes adjacent to the affected areas were edematous.
The mucosa of the upper and lower respiratory tract of calves A and B was severely congested. The medium and small airways contained a fibrinous suppurative exudate. Extensive areas of congestion, edema, and consolidation were present in cranioventral areas of all lung lobes. Fibrinous pleuritis and pericarditis were found in zones adjacent to pulmonary lesions. Regional lymph nodes were severely congested with cortical and medullary hemorrhages. No relevant gross lesions were seen in the respiratory tract of calf C.
Microbiology and serology results. Pasteurella haemolytica was isolated from lung samples of calves A and B. In addition, P. multocida was isolated from the lung of calf A. No significant microorganisms were isolated from calf C.
The concentration of BVDV NY-93 in tissues collected during necropsies as determined by end point dilution is shown in Table 1 . BVDV was isolated from all the tissues processed from all calves. The tissues with the highest BVDV NY-93 titer were esophagus, rumen, and abomasum. Virus concentrations in tissues of calf B, which died on day 13 PI, were higher than concentrations found in tissues of calf A, which was euthanized on day 14 PI. Moreover, concentrations of BVDV in tissues of the untreated control calf (calf C) were lower than those in the dexamethasone-treated calves A and B.
All calves were devoid of BVDV antibody before the experimental inoculation. No detectable virus-neutralizing antibodies against either homologous (NY-93, genotype II isolate) or heterologous (Singer isolate, genotype I) BVDV were found in samples collected daily from any the 3 calves throughout the experiment.
Histopathology. Significant microscopic lesions were present in the respiratory, digestive, and lymphoid systems. Respiratory tract lesions in both calves treated with dexamethasone included a mild acute to subacute hemorrhagic tracheitis, characterized by coagulation necrosis of epithelial cells and submucosal hemorrhages with minimal lymphocytic infiltrate. In addition, severe acute fibrinopurulent pneumonia and pleuritis were present in the anteroventral pulmonary areas. Large number of mononuclear spindle-shaped cells (oat cells) and bacterial colonies were seen in the lung sections of calf B. Severe congestion and edema of lung were present adjacent to the consolidated lung regions of both calves.
Mild degenerative changes were present in the stratum basale and stratum spinosum of the squamous epithelium of tongue, esophagus, and rumen of all calves. These changes consisted of individual cell necrosis, vacuolation, and premature keratinization of cells of the stratum spinosum. Multiple areas of epithelial necrosis, nonsuppurative inflammation and pseudomembrane formation were present in the mucosa of the esophagus of calf C. Multiple vacuolated cells were found in the basal cell layer of the stratified epithelium of the forestomachs. In some cases, several vacuolated cells coalesced, forming microvesicles. Multiple hemorrhagic foci were found on the mucosa of the abomasum, ileocecal valve ( Fig. 1A) , colon, and rectum of all calves. Calves A and B had extensive hemorrhage and edema in the gallbladder. In addition, moderate to severe edema was also present in the walls of the abomasum and rectum of these calves (data not shown). Intestinal crypt epithelial degeneration and necrosis were prominent in distal duodenum, jejunum, ileum, proximal colon, and rectum from calves A and C. The affected crypts were dilated and contained large amounts of cell debris mixed with neutrophils and macrophages (Fig. 1B) . Herniation of dilated crypts through the submucosa, filling the space vacated by necrotic or depleted lymphoid tissue, was a common feature. Submucosal and serosal lymphatics of colon and rectum were often found dilated. A moderate to severe vasculitis was present in the submucosa and serosa of ileum of calf C.
Intestinal submucosal lymphoid tissue in all calves had mild to moderate follicular lymphocytolysis characterized by pyknotic and fragmented lymphocytes and macrophages containing cellular debris. Lymphoid depletion of primary lymphoid follicles was more prominent in lymph nodes associated with the diges-tive system of calves A, B, and C and the respiratory system of calves A and B. Significant lymphoid depletion and necrosis of Peyer's patches of the jejunum and ileum was observed in calf C. Paracortical and medullary hemorrhage with serofibrinous exudate was found in retropharyngeal and mediastinal lymph nodes of calves A and B. Bronchial lymph nodes of calf B had severe sinus histiocytosis and fibrinoid necrosis of small paracortical arterioles. Severe necrotizing vasculitis was present in retropharyngeal and bronchial lymph nodes of calf C. Serofibrinous splenitis with moderate to severe lymphocytolysis and lymphoid depletion was found in calves A and B (Fig. 1C) .
Immunohistochemistry. Viral antigen distribution in tissues is summarized in Table 2 . BVDV antigen was invariably found in the squamous epithelium of tongue, esophagus, and forestomachs ( Fig. 2A) . Cells containing antigen were adjacent to vacuolated or necrotic epithelial cells. These sites and scattered abomasal crypts contained the cells that stained most intensely for BVDV antigen.
Immunohistochemical staining of the small and large intestine revealed the presence of BVDV-specific antigen in scant numbers of epithelial cells and small numbers of mononuclear cells within the lamina propria. The muscularis mucosae and myenteric ganglion neurons of the colon and rectum of calf A showed intense staining for BVDV antigen (not shown). In the gut-associated lymphoid tissue, specific viral antigen was found in cells with dendritic or macrophage morphology in depleted lymphoid follicles and interfollicular areas. This finding was particularly prominent in the Peyer's patches of calf C. The medullary regions of mesenteric and bronchial lymph nodes contained several positive mononuclear cells. In the spleen, BVDV antigen was present in macrophage-like or dendritic cells at the marginal zone of the white pulp. BVDV antigen was rarely seen in lymphocytes. In the respiratory system, BVDV antigen was noticed in few alveolar macrophages, interstitial histiocytes, and bronchiolar epithelial cells. Cytoplasmic BVDV antigen was also found in connective tissue stroma of the liver, spleen, lymph nodes, and kidney. Smooth muscle cells in the media of submucosal arteries in the large intestine and in some lymph nodes revealed viral antigen ( Fig. 2B ). Endothelial cells in hepatic sinusoids (data not shown) and submucosal arteries of the prox-imal colon also contained BVDV antigen (Fig. 2B) . Other sites where cytoplasmic antigen was detected included pituitary, pancreas, and tabular epithelium in the renal cortices (data not shown). No specific reactivity was located in central nervous system.
Discussion
Fatal and severe disease was produced by infection with the BVDV NY-93 isolate, a NCP genotype II virus, in cattle with or without concomitant dexamethasone treatment that were known to be free of BVDV and BVDV neutralizing antibodies. Experimental reproduction of disease induced by BVDV genotype II isolates has been reported. 1, 5, 12, 13 Three different BVDV isolates have been used in these studies, CD-87, CD-89, and BVD-890, all of which are known to produce profound thrombocytopenia. Those studies were mainly focused on clinical and hematologic aspects of BVDV genotype II infections.
Macroscopic lesions found in the present study are largely consistent with those reported previously in an experimental challenge with BVDV 890, another genotype II isolate. 3 Gross and microscopic lesions in the lower digestive tract and respiratory and lymphoid systems induced by NY-93 were similar to those described in MD. 18, 26, 31 However, the typical cutaneous, oral, and esophageal lesions present in MD were not seen in calves with acute BVDV NY-93 infection.
Lymphoid lesions were similar to those described in MD. 18, 38 Lymphocytolysis and lymphoid depletion of Peyer's patches was also described in a recent report of a natural outbreak of acute BVDV genotype II infection. 38 Swelling, hemorrhage and edema of mediastinal and mesenteric lymph nodes mentioned in MD were also observed in the BVDV NY-93 infections. In addition, the moderate to severe follicular lymphocytolysis in mesenteric and gut-associated lymphoid tissue of calves challenged with the genotype II isolate mimic the severe lymphocytic depletion of mesenteric lymph nodes seen in cases of MD. 3 The digestive tract lesions and virus localization in these calves are similar to those found in MD. BVDV antigen was detected in the squamous epithelium of tongue, esophagus, and forestomachs, often adjacent to vacuolated or necrotic cells, suggesting direct cellular damage by CP-BVDV replication. This finding was correlated with high titers of BVDV in these epithelia. BVDV antigen was also detected in mononuclear cells in the epithelial submucosa of the upper digestive tract, where a minimal mononuclear infiltration was detected. The role of BVDV antigen, if any, in intestinal pathology remains to be established. As described previously in cases of MD, the most severe intestinal lesions found in this study were in close association with gut-associated lymphoid tissue. 2, 18, 26 The clinical similarity and the presence of common pathologic changes in cattle with acute BVDV genotype II infections and cattle with MD complicate differential diagnoses on the basis of clinical and pathologic examinations. Definitive diagnosis of MD may require demonstration of a CP-BVDV agent in tissues.
Both dexamethasone-treated calves in the present study had severe acute bronchopneumonia associated with P. haemolytica and P. multocida. The respiratory tract is a site of primary BVDV infection and replication. 30, 39 A role of BVDV in facilitating the colonization and growth of P. haemolytica in the lungs, often resulting in severe pulmonary lesions, has been proposed. 30 The immunohistochemical detection of specific BVDV antigen in alveolar macrophages, subepithelial mononuclear cells, and bronchiolar epithelial cells suggests possible pneumotropism of the NY-93 BVDV isolate following aerosol exposure. Further evaluation of BVDV isolates for this trait may be warranted. 6 Detection of large amounts of BVDV-specific antigen in arteries of several organs is a novel finding in acute NCP-BVDV infection (Fig. 2B ). This finding was previously described in cases of MD. 18, 19 Some authors considered the involvement of blood vessel a nonspecific finding 2,3 ; however, the present results agree with recent reports describing the presence of BVDV antigen in blood vessels as a consistent finding in many tissues. 19 In these cases, BVDV antigen was also detected most frequently in smooth muscle cells of the blood vessel wall and less commonly in endothelial cells. The pathogenesis of the infection of the media of arteries remains to be elucidated. Blood vessels with BVDV-specific antigen in endothelial cells were described (Fig. 2B ), but microscopic endothelial damage was absent. BVDV may initially infect endothelial cells and may then spread from these cells to the elastic and muscular layers.
Reports on the low morbidity and mortality rates in outbred cattle experimentally inoculated with BVDV have suggested that host factors such as stress may participate in the pathogenesis. Thus, the field conditions under which severe acute BVDV is commonly observed were mimicked by injection of a synthetic glucocorticoid for a short period of time surrounding the early stage of infection. Diverse experimental conditions for the administration of dexamethasone have been reported to potentiate systemic infection with different strains of BVDV in calves. 10, 35 Clinical and pathologic features observed in cattle experimentally infected with BVDV NY-93 were similar to those observed in naturally occurring outbreaks of BVD. Dexamethasone-treated calves had severe respiratory involvement and bacterial infection, suggesting synergistic pathogenic actions of the virus and dexametha-sone exacerbating their immunosuppressive effects. The highly virulent nature of the NY-93 isolate of BVDV is postulated to be a prerequisite for the development of the severe disease and described pathology in experimentally inoculated calves. These results suggest that severe acute disease caused by NCP-BVDV is an important clinical syndrome that has been largely unrecognized. The similarity between pathologic findings presented here and those seen in cattle with naturally acquired disease supports this conclusion.
